MMAPA Companies COVID-19 Aid Efforts

The final Medicare Advantage rates for 2027 represent an important step forward by preventing additional cuts and protecting a program that serves more than 679,000 beneficiaries in Puerto Rico. This outcome reflects the impact of sustained engagement among federal leaders, the Puerto Rico government, and key stakeholders who have elevated the urgency of addressing the island’s Medicare Advantage funding challenges. However, continued collaboration with federal leadership wil

This week, a MMAPA delegation is in Washington, D.C. participating in the MHPA Policy & Leadership Forum, representing the interests of patients and Puerto Rico’s healthcare system. As part of the agenda, we met with congressional leaders to continue advancing discussions on the importance of Congress addressing Medicaid funding for the Island—an essential issue to ensure an adequate and accessible healthcare system. Among these meetings, we engaged with Jonathan Kupperman of

That is why each year’s Medicare Advantage payment policies are so important for the stability of healthcare on the Island. The Medicaid and Medicare Advantage Products Association of Puerto Rico (MMAPA) submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the 2027 Medicare Advantage Advance Notice. In our letter, we highlight the importance of ensuring that payment methodologies accurately reflect markets where Medicare Advantage is the prim